BlackRock Advisors’s Kite Pharma, Inc. KITE Stock Holding History

BlackRock Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.9M	Sell	42,430 -6,204	-13%	-$304K	﹤0.01%	1542
2016 Q3	$2.72M	Buy	48,634 +2,311	+5%	+$129K	﹤0.01%	1354
2016 Q2	$2.32M	Buy	46,323 +10,685	+30%	+$525K	﹤0.01%	1377
2016 Q1	$1.64M	Sell	35,638 -6,064	-15%	-$294K	﹤0.01%	1519
2015 Q4	$2.57M	Buy	41,702 +3,736	+10%	+$263K	﹤0.01%	1314
2015 Q3	$2.11M	Buy	37,966 +3,918	+12%	+$246K	﹤0.01%	1344
2015 Q2	$2.08M	Buy	34,048 +28,204	+483%	+$1.61M	﹤0.01%	1255
2015 Q1	$337K	Sell	5,844 -45,877	-89%	-$3.07M	﹤0.01%	2367
2014 Q4	$2.98M	Buy	51,721 +21,944	+74%	+$924K	﹤0.01%	1085
2014 Q3	$849K	Buy	+29,777	New	+$737K	﹤0.01%	1541

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

BlackRock Advisors's KITE Position: Q4 2016 in Review

BlackRock Advisors reduced its Kite Pharma, Inc. (KITE) stake by 13% in Q4 2016, selling an estimated $304K and leaving 42,430 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

BlackRock Advisors first reported a position in KITE in Q3 2014 and has held it in 10 quarters since. The position peaked at $2.98M in Q4 2014. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

BlackRock Advisors held 42,430 shares of Kite Pharma, Inc. worth $1.9M as of Q4 2016.
BlackRock Advisors sold 6,204 Kite Pharma, Inc. shares in Q4 2016, an estimated $304K.
Kite Pharma, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1542 holding.
BlackRock Advisors first reported a position in Kite Pharma, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Advisors's Kite Pharma, Inc. position peaked at $2.98M in Q4 2014.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.